Literature DB >> 10365924

Finasteride in the treatment of men with frontal male pattern hair loss.

J Leyden1, F Dunlap, B Miller, P Winters, M Lebwohl, D Hecker, S Kraus, H Baldwin, A Shalita, Z Draelos, M Markou, D Thiboutot, M Rapaport, S Kang, T Kelly, D Pariser, G Webster, M Hordinsky, R Rietschel, H I Katz, L Terranella, S Best, E Round, J Waldstreicher.   

Abstract

BACKGROUND: Finasteride, a specific inhibitor of type II 5alpha-reductase, decreases serum and scalp dihydrotestosterone and has been shown to be effective in men with vertex male pattern hair loss.
OBJECTIVE: This study evaluated the efficacy of finasteride 1 mg/day in men with frontal (anterior/mid) scalp hair thinning.
METHODS: This was a 1-year, double-blind, placebo-controlled study followed by a 1-year open extension. Efficacy was assessed by hair counts (1 cm2 circular area), patient and investigator assessments, and global photographic review.
RESULTS: There was a significant increase in hair count in the frontal scalp of finasteride-treated patients (P < .001), as well as significant improvements in patient, investigator, and global photographic assessments. Efficacy was maintained or improved throughout the second year of the study. Finasteride was generally well tolerated.
CONCLUSION: In men with hair loss in the anterior/mid area of the scalp, finasteride 1 mg/day slowed hair loss and increased hair growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365924     DOI: 10.1016/s0190-9622(99)70081-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  27 in total

1.  Direct-to-consumer advertising. Finasteride for male pattern hair loss.

Authors:  A Cassels; J M Wright; B Mintzes; C Jauca
Journal:  Can Fam Physician       Date:  2001-09       Impact factor: 3.275

Review 2.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

Review 3.  Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.

Authors:  Charles Welliver; Michael Butcher; Yogitha Potini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

4.  Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?

Authors:  Meena K Singh; Marc Avram
Journal:  J Clin Aesthet Dermatol       Date:  2014-12

5.  The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.

Authors:  Motoki Tanaka; Takunori Ogaeri; Mikhail Samsonov; Masahiro Sokabe
Journal:  Transl Stroke Res       Date:  2018-03-25       Impact factor: 6.829

6.  Hair evaluation methods: merits and demerits.

Authors:  Rachita Dhurat; Punit Saraogi
Journal:  Int J Trichology       Date:  2009-07

Review 7.  [New and established methods in therapy of hair diseases].

Authors:  R M Trüeb
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

8.  Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.

Authors:  P Mirmirani; M Consolo; P Oyetakin-White; E Baron; P Leahy; P Karnik
Journal:  Br J Dermatol       Date:  2014-12-10       Impact factor: 9.302

9.  Understanding Women's Vaginal Douching Behaviors and Practices for Consideration in the Development of a Potential Future Vaginal Microbicide Douche for HIV Prevention: A Systematic Review of the Literature.

Authors:  Christine Tagliaferri Rael; Doyel Das; Jose Bauermeister; Cody Lentz; Alex Carballo-Diéguez; Rebecca Giguere; Rachel K Scott; Craig W Hendrix
Journal:  AIDS Behav       Date:  2021-05-12

10.  Perception of Hair Transplant for Androgenetic Alopecia.

Authors:  Kristin L Bater; Masaru Ishii; Andrew Joseph; Peiyi Su; Jason Nellis; Lisa E Ishii
Journal:  JAMA Facial Plast Surg       Date:  2016-12-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.